Persistent Lip Ulcer: Assessing Actinic Cheilitis and Suspected Cancer

What distinguishes actinic cheilitis from lip cancer?

Actinic cheilitis is chronic ultraviolet-related damage to the vermilion, the coloured transition between facial skin and the inner lip. It usually affects the lower lip. Findings include dryness, scaling, thinning, patchy redness or whiteness, and loss of a clear border between lip and skin.

Squamous cell carcinoma is cancer arising from the surface lining cells. It may appear as a persistent ulcer, crusted focus, thickened plaque or growing nodule. Early cancer can be small and painless, without an obvious neck lump.

These diagnoses are not mutually exclusive. A focal cancer can develop within a wider area of actinic change. The practical question is whether any part of the lip requires tissue diagnosis, not simply whether the overall appearance resembles sun damage.

• ·Diffuse roughness and a blurred vermilion border suggest actinic damage but do not exclude cancer.
• ·Focal induration, meaning abnormal firmness beneath a lesion, raises concern for invasion into deeper tissue.
• ·Ulceration, persistent crusting, spontaneous bleeding or a newly thickened area should guide biopsy assessment.
• ·Colour, pain and lesion size alone cannot reliably separate inflammation, precancerous change and invasive disease.

Which alternative diagnoses should be considered?

First establish whether the lesion involves external skin, vermilion or inner labial mucosa, the lining inside the lip. Location changes the differential diagnosis. An inner-lip ulcer is not automatically actinic cheilitis because the patient also has sun-damaged lips.

Use the history and surrounding findings to narrow possibilities. A possible traumatic cause or inflammatory background does not cancel a suspicious examination.

• ·Traumatic ulcer: a corresponding sharp tooth, denture edge or biting habit may explain the site. Document complete healing after the cause is addressed.
• ·Irritant or allergic cheilitis: often diffuse redness, scaling and fissuring associated with contact exposure or lip licking. A persistent focal ulcer still needs separate assessment.
• ·Recurrent viral ulceration: usually episodic, with a recognisable course and healing between attacks. One continuously ulcerated site is atypical.
• ·Aphthous ulceration: recurrent, usually painful ulcers on inner oral lining, with healing between episodes. Chronic vermilion ulceration is not a typical presentation.
• ·Immune-mediated disease: lichenoid inflammation, lupus-related disease or blistering disorders may produce erosions, meaning shallow surface loss. Look for additional oral, skin or eye involvement.
• ·Infection: consider when immune suppression, exposure history or systemic findings support it. Testing should be targeted rather than used to delay biopsy.
• ·Other malignancy: an unusual skin-based lesion, pigment change or submucosal mass may require a broader dermatological or head-and-neck assessment.

What history changes the level of concern?

Record when the lesion began, whether it ever fully healed, and what has changed. Repeated crust formation at the same site may represent a continuously abnormal lesion rather than separate episodes. Ask about growth, bleeding, altered sensation and functional symptoms.

Assess cumulative sun exposure through occupation, travel and recreation. Outdoor work in Mumbai, Thane or surrounding districts can be relevant, but geography alone does not establish the diagnosis. Absence of tobacco use does not exclude lip cancer.

• ·Document tobacco, smokeless tobacco, areca nut and alcohol exposure without making these prerequisites for referral.
• ·Ask about previous skin or oral cancer, prior lip procedures, immune suppression and organ transplantation.
• ·Record lip biting, dental trauma, denture contact, lip products and occupational exposures.
• ·Ask specifically about a lump, numbness, unexplained bleeding, difficulty opening the mouth and difficulty swallowing.
• ·Review earlier photographs, biopsy reports and treatment history. Temporary symptom relief does not prove that the underlying lesion is benign.

What examination sequence is useful?

An in-person examination is required for a persistent lip ulcer. Photographs can support triage, but they cannot assess firmness, fixation or regional lymph nodes. Explain that examination of the whole mouth and neck is necessary even when the complaint is confined to the lip.

Use good lighting and document the lesion before any intervention that changes its appearance. Avoid recording only 'lip ulcer'; the distribution and palpable findings influence both biopsy selection and referral urgency.

• ·Inspect both lips at rest and with gentle eversion. Identify external skin, vermilion, inner lining and the corners of the mouth.
• ·Measure the lesion and describe ulceration, crust, scale, red or white change, border definition and surrounding sun damage.
• ·Palpate gently for induration, thickness, tenderness and fixation to deeper structures. Compare with the opposite side.
• ·Assess lower-lip and chin sensation, lip movement, mouth opening and any reported swallowing difficulty.
• ·Examine the entire oral cavity, including lateral tongue, floor of mouth and other sites that may contain a separate lesion.
• ·Examine regional lymph nodes, especially beneath the chin, beneath the jaw and along the neck. Record size, tenderness, mobility and firmness of any palpable node.
• ·Take consented clinical photographs and create a site map if several areas differ in appearance.

Which findings require urgent or emergency referral?

A non-healing ulcer beyond two weeks requires in-person assessment. Do not wait for that threshold when induration, progressive growth, unexplained bleeding, numbness or a suspicious lump is already present. Pain is not required for urgent action.

For suspected cancer, initiate an urgent referral at the assessment visit. Use the local suspected-cancer pathway and request assessment within two weeks where available. This is a practical urgency target, not a claim that every Indian service operates the same referral system.

• ·Refer urgently for a persistent unexplained ulcer, firm or fixed lesion, enlarging nodule, irregular raised edge or focal ulcer within actinic change.
• ·A new neck lump, lower-lip or chin numbness, difficulty opening the mouth or difficulty swallowing increases concern and should be stated prominently in the referral.
• ·Rapid progression or significant immune suppression warrants a low threshold for urgent specialist discussion.
• ·Arrange same-day emergency assessment for airway compromise, inability to manage saliva, major uncontrolled bleeding or inability to maintain hydration.
• ·A clearly traumatic, non-suspicious lesion may have a short, documented healing review after the cause is addressed. Do not restart observation repeatedly or defer referral for an already persistent, suspicious lesion.

When is biopsy indicated, and how should it be planned?

Biopsy is indicated when cancer or epithelial dysplasia is suspected. Dysplasia means abnormal changes in the lining cells that may precede cancer. In actinic cheilitis, focal persistent ulceration, thickening, firmness, bleeding or an unexplained changing area should prompt tissue assessment.

Not every diffusely dry lip needs immediate biopsy. However, diagnostic uncertainty, persistent abnormalities or consideration of tissue-destructive treatment requires specialist assessment of whether histology is needed. Histology is microscopic examination of tissue.

A clinician experienced in lip biopsy should select a representative site and a sampling approach capable of assessing invasion. A sample containing only crust or dead tissue may be uninformative. Different-looking areas may require separate samples because one small specimen cannot describe the entire damaged field.

• ·Incisional biopsy, which samples part of a lesion, is often appropriate for a larger suspicious area. Complete removal of a small lesion may be suitable in selected circumstances.
• ·Plan the approach with the receiving surgeon when lesion size, depth, location or future reconstruction could make an initial procedure consequential.
• ·Provide the pathologist with the exact site, duration, clinical differential, photographs where available and any concern about invasion.
• ·If immune-mediated blistering disease is suspected, discuss additional specimen requirements with the specialist and laboratory before biopsy.
• ·Do not use a reassuring surface test, light-based adjunct or brush sample as a substitute for indicated tissue biopsy.

When does imaging help?

Imaging is not routinely required to distinguish uncomplicated actinic cheilitis from a small superficial cancer. It cannot determine epithelial dysplasia and does not replace biopsy. For an accessible suspicious ulcer, routine imaging should not become a barrier to tissue diagnosis.

Imaging becomes relevant when examination suggests deeper extension, nodal disease, bone involvement or spread along a nerve. The receiving cancer team should select staging investigations according to the lesion's site, clinical findings and pathology.

• ·Neck ultrasound may help assess an abnormal lymph node and support image-guided sampling when indicated.
• ·Contrast-enhanced computed tomography, or CT, can help assess deeper structures, bone and regional disease in selected cases.
• ·Magnetic resonance imaging, or MRI, may be useful for soft-tissue extent or suspected perineural spread, meaning tumour spread along a nerve.
• ·Dental panoramic imaging and cone-beam CT do not adequately stage a lip soft-tissue malignancy.
• ·Advanced staging imaging is not a routine screening investigation for every persistent lip ulcer.

Where should the patient be referred?

For a persistent but diagnostically uncertain lesion without clear invasive features, refer promptly to oral medicine or dermatology with experience in lip disease and access to biopsy. Oral and maxillofacial surgery is also appropriate when tissue diagnosis or surgical assessment is needed.

For clinically suspected invasive cancer, refer directly to a head-and-neck cancer service or a surgeon experienced in lip malignancy. Depending on local organisation, this may be oral and maxillofacial surgical oncology, ear, nose and throat head-and-neck surgery, surgical oncology or a specialist skin-cancer service.

External skin, vermilion and inner mucosal lesions may enter different staging and treatment pathways. State the exact origin rather than assuming all lip cancers are managed identically. The receiving multidisciplinary team should resolve that distinction.

• ·In Mumbai and the wider Thane region, choose a service with pathology access, appropriate neck assessment and multidisciplinary cancer care when malignancy is suspected.
• ·Include duration, dimensions, photographs, palpation findings, sensory changes, nodes, risk factors and previous histology.
• ·State 'suspected lip malignancy' when justified rather than using a routine cosmetic or general dental referral.
• ·Track whether the appointment occurred and whether biopsy results were reviewed. If access is delayed, contact the receiving service or identify an alternative urgent pathway.

What care follows the pathology result?

Actinic cheilitis care includes reducing further ultraviolet exposure and specialist selection of treatment for the affected field. Options include clinician-directed field treatment, ablative procedures that remove damaged surface tissue, or surgical removal of affected vermilion. Dermatology, oral medicine and appropriately experienced surgical teams may share care.

Confirmed invasive cancer requires specialist cancer management. Surgical removal with assessment of the tissue edges is a common approach. Reconstruction, regional lymph-node management, radiotherapy or systemic oncology care may be considered according to disease extent and multidisciplinary review.

Treatment selection should account for function, sensation, lip closure and appearance as well as cancer control. Tissue-destructive care should not precede adequate assessment of a suspicious focal lesion.

• ·Dysplasia without invasion requires a specialist plan based on the pathology, extent and clinical findings.
• ·A report of inflammation alone does not settle the diagnosis if a firm, enlarging or ulcerated lesion remains.
• ·Clinical–pathological discordance, meaning that the examination and biopsy result do not agree, warrants specialist review and possibly further sampling.
• ·Arrange an individualised follow-up plan. New ulceration, thickening, bleeding, numbness or a lump needs reassessment rather than waiting for the next scheduled visit.

Which guideline principles support these decisions?

The American Dental Association's 2017 evidence-based guideline on evaluating potentially malignant disorders in the oral cavity supports immediate biopsy or specialist referral for clinically suspicious lesions. Its central principle applies to mucosal assessment: adjunctive tests should not delay definitive tissue diagnosis. It is not a dedicated actinic-cheilitis guideline.

NICE guideline NG12, Suspected cancer: recognition and referral, advises a suspected-cancer pathway referral for unexplained oral ulceration lasting more than three weeks or a persistent unexplained neck lump. It also addresses urgent assessment of lip or oral lumps. The two-week examination threshold used here is a safety-netting threshold, not a quotation of the NICE ulcer-duration criterion.

The American Academy of Dermatology's guideline for cutaneous squamous cell carcinoma supports adequate biopsy sampling, risk-based imaging and specialist management. Its scope is cutaneous cancer; the applicable pathway for a vermilion or inner-lip lesion must be confirmed by the treating team. These principles support prompt diagnosis without treating every lip lesion as identical.

• ·ADA oral cancer guideline resources: https://www.ada.org/resources/research/science-and-research-institute/evidence-based-dental-research/oral-cancer-guideline
• ·NICE NG12, recommendations organised by cancer site: https://www.nice.org.uk/guidance/ng12/chapter/1-recommendations-organised-by-site-of-cancer
• ·American Academy of Dermatology, cutaneous squamous cell carcinoma guideline resources: https://www.aad.org/member/clinical-quality/guidelines/scc